Spots Global Cancer Trial Database for Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
Official Title: Multicenter, Randomized, Controlled, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2 or IFN Based Therapy
Study ID: NCT00055562
Interventions
Study Description
Brief Summary: Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Subjects will be treated in repeating 4 week cycles.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Arizona Cancer Center, Tucson, Arizona, United States
University of Southern California Norris Cancer Center, Los Angeles, California, United States
UCLA, Los Angeles, California, United States
St. Francis Memorial Hospital, San Francisco, California, United States
Outpatient Clinic, Santa Monica, California, United States
University of Colorado, Aurora, Colorado, United States
The Harold Lever Regional Cancer Center, Waterbury, Connecticut, United States
Lakeland Regional Cancer Center, Lakeland, Florida, United States
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
Lutheran General, Park Ridge, Illinois, United States
Carle Clinic, Urbana, Illinois, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States
Spectrum Health, Grand Rapids, Michigan, United States
Ellis Fischel Cancer Center, Columbia, Missouri, United States
Washington University School of Medicine, St. Louis, Missouri, United States
Melanoma Center of St Louis, St. Louis, Missouri, United States
Biomedical Research Alliance of New York, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
The Linder Clinical Trial Center, Cincinnati, Ohio, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Penn State Hershey Medical Center, Hershey, Pennsylvania, United States
UPMC Cancer Pavillion, Pittsburgh, Pennsylvania, United States
Sarah Cannon Cancer Center, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
Tom Baker Cancer Center, Calgary, Alberta, Canada
Cross Cancer Institute, Edmonton, Alberta, Canada
Cancer Care Manitoba, Winnipeg, Manitoba, Canada
Qell Health Sciences Center, Halifax, Nova Scotia, Canada
Princess Margaret Hospital, Toronto, Ontario, Canada
L'Hotel Dieu de Quebec, Quebec, , Canada
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
